Arie Belldegrun received his medical degree from the Hadassah Medical Center at Hebrew University of Jerusalem in 1974, and conducted his post-graduate studies at the Weizmann Institute of Science in 1979.
20 Facts About Arie Belldegrun
1.
2.
Arie Belldegrun completed his urologic surgery residency at Harvard Medical School in 1985, and his Surgical Oncology fellowship at the National Cancer Institute in 1988.
3.
Arie Belldegrun is certified by the American Board of Urology, and is a fellow of the American College of Surgeons and the American Association of Genitourinary Surgeons.
4.
In 1996, Arie Belldegrun established his first company, Agensys, which was an early-stage privately held biotechnology company based in Los Angeles.
5.
Arie Belldegrun was focused on the development of fully human monoclonal antibodies to treat solid tumor cancers in a variety of cancer targets.
6.
Arie Belldegrun served as its founding chairman of the board of directors from 1996 to 2002, and then as a director.
7.
In 2003, Arie Belldegrun became the founding vice-chairman of the board of directors and chairman of the scientific advisory board of Cougar Biotechnology; the company had a focus in the field of oncology.
8.
In 2008, Arie Belldegrun became the chairman and partner of Two River, a New York-based venture capital firm and merchant bank focused on the life science sector.
9.
Arie Belldegrun is the founder, chairman, president and CEO of Kite Pharma.
10.
In 2017, Arie Belldegrun became the co-founder and senior managing director of Vida Ventures, a Boston-based life sciences investment firm that consists of scientists, physicians, entrepreneurs, and investors passionate about building and funding breakthroughs in biomedicine.
11.
Arie Belldegrun serves as the co-chairman, while his son, Dan, is the company's CEO.
12.
Arie Belldegrun purchased its first property in Boston's Seaport District for $80 million.
13.
Arie Belldegrun serves on the board of directors of Ginkgo Bioworks.
14.
Arie Belldegrun serves on the board of directors of Kronos Bio, Fosun Kite, UroGen Pharma, Pontifax, ByHeart and IconOVir Bio.
15.
Arie Belldegrun is married to Rebecka Arie Belldegrun and together they have four children.
16.
In 2014, according to the Bloomberg Pay Index, Arie Belldegrun was ranked the 8th highest-paid executive in the United States, with a pay package valued at $95.2 million.
17.
Arie Belldegrun was featured in the CEO Today USA Awards 2017 which celebrate the success, innovation and strategic vision of CEOs across a number of sectors, industries within the US, identifying the most successful, innovative and forward-thinking CEOs in business today.
18.
In June 2018, Arie Belldegrun received the EY Master Entrepreneur Award at the Entrepreneur of the Year 2018 Awards.
19.
Arie Belldegrun has written over 500 scientific publications related to urologic oncology and has authored several books on prostate and kidney cancers.
20.
Arie Belldegrun serves as a member of the advisory board of the Vagelos Program in Life Sciences and Management at the University of Pennsylvania and as a member of the strategic advisory group of the Parker Institute for Cancer Immunotherapy.